סלברייט מודיעה על תוצאות הרבעון הרביעי של 2022

Cellebrite (נאסד"ק: CLBT), מובילה עולמית בפתרונות בינה דיגיטלית ("DI") למגזר הציבורי והפרטי, הודיעה היום על התוצאות הכספיות לשלושת ו-12 החודשים שהסתיימו ב-31 בדצמבר 2022.

Cellebrite Announces Fourth Quarter 2022 Results

ARR of $249 million, up 33% year-over-year

Fourth-quarter revenue of $74.0 million, Increase 9% year-over-year

Fourth-quarter adjusted EBITDA of $16.1 million, 21.8% adjusted EBITDA margin

PETAH TIKVA and TYSONS CORNER, Va., Feb. 15, 2023 (GLOBE NEWSWIRE):

Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence (“DI”) solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2022.

“We ended 2022 with solid quarterly results fueled by our industry-leading technology in a healthy Digital Intelligence market. Our market leadership remains strong as a result of the tangible progress and investments we have made in innovating across our platforms and executing on our go-to-market strategy,” said Yossi Carmil, Cellebrite’s CEO. “As data volumes are surging, data complexity is increasing and scrutiny around ethics and accountability are mounting, we are committed to helping customers modernize their investigations by digitizing the evidence workflows end-to-end. We enter 2023 well positioned to accelerate our revenue growth rate and drive improved profitability as we continue to capitalize on the strong demand we see for our offerings.”

Fourth Quarter Financial Highlights

• Annual RecurringRevenue (ARR) of $249 million, up 33% year-over-year
• Revenue of $74.0million, up 9% year-over-year, of which subscription revenue was $62.3million, up 24% year-over-year
• Recurring revenuedollar-based net retention rate of 130%
• GAAP gross profitand gross margin of $61.9 million and 83.6%, respectively
• GAAP net income of$7.1 million; Non-GAAP net income of $15.3 million
• GAAP diluted EPSof $0.04; Non-GAAP diluted EPS of $0.08
• Adjusted EBITDAand adjusted EBITDA margin of $16.1 million and 21.8%, respectively

Full Year Financial Highlights

• Revenue of $270.7million, up 10% year-over-year, of which subscription revenue was $216.0million, up 18% year-over-year
• GAAP gross profitand gross margin of $219.9 million and 81.3%, respectively
• GAAP net income of$120.8 million; Non-GAAP net income of $19.7 million
• Adjusted EBITDAand Adjusted EBITDA margin of $25.9 million and 10%, respectively

Fourth Quarter and Recent Digital Intelligence Highlights

• Closed 29 largedeals in the fourth quarter, each valued at $500,000 or more.
• Won a $14 millionagreement with a leading law enforcement agency in Asia for thecompany’s Advanced Extraction Solution.
• Signed a $10+ million deal with a major West Europeannational police force, marking one of the Company’s largest digital intelligencedeals, further validating digital intelligence as an essential acceleratorfor investigators.
• Announced that itscollaboration with the Vanderburgh Co. Cyber Crime Task Force to service29 agencies across 11 U.S. states has helped accelerate justice byreducing the time it takes to investigate and successfully prosecute felonies.
• Launched new cloud workplace app collection capability forCellebrite Endpoint Inspectorthataims to improve organizations’investigation and eDiscovery capabilities. Thisnew functionalitywillenable customers to collect remote mobile and computer data as well ascloud workplace application data in one unified platform, reducing timeand costs associated with the collection of data of these apps.
• Publishedthe Enterprise Solutions 2023 Industry Trends Report,which highlights major data collection headaches arising from a hybridwork environment that threaten to slow down corporate fraud, IP theft andsexual harassment investigations for eDiscovery professionals andcorporate investigators.
• Partneredwith the Gangmasters and Labour Abuse Authority (GLAA), and The Exodus Road to help these organizationsadvance their efforts to advance their respective missions and eliminateforced labor and human trafficking.

Supplemental financial information can be found on the Investor Relations section of our website at https://investors.cellebrite.com/financial-information/quarterly-results.

Financial Outlook

“With a strong 33% annual growth in ARR during 2022 and 84% of our fourth-quarter 2022 revenue coming from subscription software licenses, Cellebrite has largely completed a successful, multi-year transition to subscription software,” said Dana Gerner, Chief Financial Officer of Cellebrite. “Looking ahead, we are well positioned to increase our revenue growth rate and sustain solid ARR momentum in 2023 as we continue expanding wallet share with existing customers, complemented by winning new logos. We anticipate that the combination of our top-line growth and prudent investment in our operations will enable us to drive improvement in our profitability during 2023, and keep us on track to reach our original long-term EBITDA margin target of 20% or greater.”

• December 2023 ARRis expected to be between $300 and $310 million, representing 21-25% yearon year growth.
• Full year 2023revenue is expected to be between $305 and $315 million, representing13-16% year on year growth.
• Full year 2023Adjusted EBITDA is expected to be between $35.0 and $40.0 million,representing 11-13% margin.

Conference Call Information
Today, February 15, 2023, at 8:30 a.m. ET, Cellebrite will host a conference call and webcast to discuss the Company's financial results for the fourth quarter 2022. The call details are below:

Telephone participants are advised to register in advance at:
https://register.vevent.com/register/BIa98ecd8f02c04567a1515497e1f850c8.

Upon registration, participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID.

The live conference call will be webcast in listen-only mode at: https://edge.media-server.com/mmc/p/6j7zngzy.

The webcast will remain available after the call at: https://investors.cellebrite.com/events-presentations

Non-GAAP Financial Information

This press release includes non-GAAP financial measures. Cellebrite believes that the use of non-GAAP net income, non-GAAP operating income and Adjusted EBITDA is helpful to investors. These measures, which the Company refers to as our non-GAAP financial measures, are not prepared in accordance with GAAP.

The Company believes that the non-GAAP financial measures provide a more meaningful comparison of its operational performance from period to period and offers investors and management greater visibility to the underlying performance of its business. Mainly:

• Share-based compensationexpenses utilize varying available valuation methodologies, subjectiveassumptions and a variety of equity instruments that can impact acompany's non-cash expenses;
• Acquiredintangible assets are valued at the time of acquisition and are amortized overan estimated useful life after the acquisition, and acquisition-relatedexpenses are unrelated to current operations and neither are comparable tothe prior period nor predictive of future results;
• To the extent thatthe above adjustments have an effect on tax (income) expense, such aneffect is excluded in the non-GAAP adjustment to net income;
• Tax expense,depreciation and amortization expense vary for many reasons that are oftenunrelated to our underlying performance and make period-to-period comparisonsmore challenging; and
• Financialinstruments are remeasured according to GAAP and vary for many reasonsthat are often unrelated to the Company’s current operations and affectfinancial income.

Each of our non-GAAP financial measures is an important tool for financial and operational decision making and for evaluating our own operating results over different periods of time. The non-GAAP financial measures do not represent our financial performance under U.S. GAAP and should not be considered as alternatives to operating income or net income or any other performance measures derived in accordance with GAAP. Non-GAAP measures should not be considered in isolated from, or as an alternative to, financial measures determined in accordance with GAAP. Non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in our industry, as other companies in our industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items. In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, and exclude expenses that may have a material impact on our reported financial results. Further, share-based compensation expense has been, and will continue to be for the foreseeable future, significant recurring expenses in our business and an important part of the compensation provided to our employees. In addition, the amortization of intangible assets is expected recurring expense over the estimated useful life of the underlying intangible asset and acquisition-related expenses will be incurred to the extent acquisitions are made in the future. Furthermore, foreign exchange rates may fluctuate from one period to another, and the Company does not estimate movements in foreign currencies.

A reconciliation of each of these non-GAAP financial measures to their most comparable GAAP measure is set forth in a table included at the end of this press release, which is also available on our website at https://investors.cellebrite.com.

Key Performance Indicators

This press release also includes key performance indicators, including annual recurring revenue and dollar-based retention rate.

Annual recurring revenue (“ARR”) is defined as the annualized value of active term-based subscription license contracts and maintenance contracts related to perpetual licenses in effect at the end of that period. Term-based license contracts and maintenance contracts for perpetual licenses are annualized by multiplying the revenue of the last month of the period by 12. The annualized value of contracts is a legal and contractual determination made by assessing the contractual terms with our customers. The annualized value of maintenance contracts is not determined by reference to historical revenue, deferred revenue or any other GAAP financial measure over any period. ARR is not a forecast of future revenues, which can be impacted by contract start and end dates and renewal rates.

Dollar-based net retention rate (“NRR”) is calculated by dividing customer recurring revenue by base revenue. We define base revenue as recurring revenue we recognized from all customers with a valid license at the last quarter of the previous year period, during the four quarters ended one year prior to the date of measurement. We define our customer revenue as the recurring revenue we recognized during the four quarters ended on the date of measurement from the same customer base included in our measure of base revenue, including recurring revenue resulting from additional sales to those customers.

About Cellebrite

Cellebrite’s (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com.

Contacts:

Investors
Investor Relations
[email protected]

Media
Victor Cooper
Public Relations and Corporate Communications Director
+1 404 804 5910
[email protected]

*** הידיעה מופצת בעולם על ידי חברת התקשורת הבינלאומית GLOBE NEWSWIRE